These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 31842156)

  • 21. The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
    Dudani S; Marginean H; Gotfrit J; Tang PA; Monzon JG; Dennis K; Kennecke HF; Powell ED; Babak S; Cheung WY; Vickers MM
    Dis Colon Rectum; 2021 Dec; 64(12):1471-1478. PubMed ID: 34657078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal Cancer.
    Ishioka M; Chino A; Ide D; Saito S; Igarashi M; Nagasaki T; Akiyoshi T; Nagayama S; Fukunaga Y; Ueno M; Kawachi H; Yamamoto N; Fujisaki J; Konishi T
    Dis Colon Rectum; 2021 Jan; 64(1):53-59. PubMed ID: 32639283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Insight Into the Driver Mutations and Molecular Mechanisms Underlying Mucinous Adenocarcinoma of the Rectum.
    Reynolds IS; O'Connell E; Fichtner M; Blümel A; Mason SE; Kinross J; McNamara DA; Kay EW; O'Connor DP; Das S; Burke JP; Prehn JHM
    Dis Colon Rectum; 2021 Jun; 64(6):677-688. PubMed ID: 33955407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
    Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
    Kohrman NM; Wlodarczyk JR; Ding L; McAndrew NP; Algaze SD; Cologne KG; Lee SW; Koller SE
    Dis Colon Rectum; 2024 Jul; 67(7):920-928. PubMed ID: 38498775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience.
    Crimì F; Spolverato G; Lacognata C; Garieri M; Cecchin D; Urso ED; Zucchetta P; Pucciarelli S; Pomerri F
    Dis Colon Rectum; 2020 Mar; 63(3):310-318. PubMed ID: 31842163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonoperative Management Versus Radical Surgery of Rectal Cancer After Neoadjuvant Therapy-Induced Clinical Complete Response: A Markov Decision Analysis.
    de Buck van Overstraeten A; Khorasani S; Kennedy E; Look Hong NJ
    Dis Colon Rectum; 2020 Aug; 63(8):1080-1089. PubMed ID: 32398412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
    Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary Report From the Pelvic Floor Disorders Consortium: Large-Scale Data Collection Through Quality Improvement Initiatives to Provide Data on Functional Outcomes After Rectal Prolapse Repair.
    Cavallaro PM; Vogler SA; Hyman NH; Ky AJ; Savitt LR; Tyler KM; Gurland BH; Bordeianou L;
    Dis Colon Rectum; 2021 Aug; 64(8):986-994. PubMed ID: 33951690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective Study.
    São Julião GP; Fernández LM; Vailati BB; Habr-Gama A; Azevedo JM; Santiago IA; Parés O; Parvaiz A; Vendrely V; Rullier A; Rullier E; Denost Q; Perez RO
    Dis Colon Rectum; 2024 Jan; 67(1):73-81. PubMed ID: 37493198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial.
    Rouanet P; Rullier E; Lelong B; Maingon P; Tuech JJ; Pezet D; Castan F; Nougaret S;
    Dis Colon Rectum; 2022 Aug; 65(8):986-995. PubMed ID: 34759247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study.
    Quezada-Diaz FF; Smith JJ; Jimenez-Rodriguez RM; Wasserman I; Pappou EP; Patil S; Wei IH; Nash GM; Guillem JG; Weiser MR; Paty PB; Garcia-Aguilar J
    Dis Colon Rectum; 2020 Jul; 63(7):897-902. PubMed ID: 32217857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
    Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
    Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.